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Abstract
Situs inversus totalis is is a congenital anomaly associated with various visceral abnormalities, but there is no data
about the relationship between secondary biliary cirrhosis and that condition. We here present a case of a 58 year-
old female with situs inversus totalis who was admitted to our clinic with extrahepatic cholestasis. After excluding
all potential causes of biliary cirrhosis, secondary biliary cirrhosis was diagnosed based on the patient’s history,
imaging techniques, clinical and laboratory findings, besides histolopathological findings. After treatment with
tauroursodeoxycholic acid, all biochemical parameters, including total/direct bilirubin, alanine aminotransferase,
aspartate aminotransferase, alkaline phosphatase and gama glutamyl transferase, returned to normal ranges at the
second month of the treatment. We think that this is the first case in literature that may indicate the development
of secondary biliary cirrhosis in a patient with situs inversus totalis. In conclusion, situs inversus should be
considered as a rare cause of biliary cirrhosis in patients with situs inversus totalis which is presented with
extrahepatic cholestasis.
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Background
Situs inversus totalis (SIT) is a congenital anomaly char-
acterized by complete transposition of abdominal and
thoracic organs. As a birth defect in newborn infants, it
has an estimated incidence of 1/15000 to 10000 cases in
live births, with a male/female ratio of 3:2. Generally,
this rare anomaly is diagnosed incidentally during thor-
acic and abdominal imaging. The cause of situs inversus
(SI) is unknown. More than one genetic mutations
including gene mutations which cause ciliopathy and
cystic renal diseases were implicated in etiopathogenesis
[1]. SIT is associated with various gastrointestinal
abnormalities. In the current literature, development of
intestinal ischemia due to intestinal malrotation, and
also acute appendicitis and liver transplantation due to
juvenile biliary atresia were reported [2-4]. However,
there is no data for the development of secondary biliary
cirrhosis (SBC) due to extrahepatic cholestasis in a
patient with SIT. We here presented a case of SIT with
SBC who referred to our clinic due to extrahepatic
cholestasis.
Case presentation
A 58-year-old female patient, who complained of icterus
appearing in the last 6-7 months, along with the symp-
toms of fatigue and loss of appetite continued for 2-3
years, was referred to our clinic. According to her medi-
cal history, she had been referred to a clinic because of
abdominal pain in the left lower quadrant and examined
due to acute abdominal pain when she was 6 years old.
She had undergone a surgical operation due to acute
appendicitis located in the left lower quadrant and the
SIT was diagnosed on those days. Furthermore, fre-
quently recurrent upper respiratory tract infections,
hypertension and a previous cholecystectomy (19 years
ago) were found in her medical history. The patient was
a smoker (26 packs/year) but she did not consume alco-
hol. In detailed personal history, she did not have any
hepatotoxic drug usage in past three months. In her phy-
sical examination, icteric appearance, moderate hepato-
megaly and kyphosis was detected. Her initial laboratory
findings were as follows: aspartate aminotransferase
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gama glutamyl transferase (GGT) 252 U/L, alkaline phos-
phatase (ALP) 153 U/L, bilirubin (total/direct) 22.7/21.4
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creatinine and electrolytes were in normal range. In addi-
tion, markers of viral hepatitis (anti-HAV IgM, anti-HBc
IgM, HBsAg, anti-HCV, TORCH), serology of autoim-
mune hepatitis (anti-nuclear antibody (ANA), anti-
smooth muscle antibody (ASMA), anti-mitochondrial
antibody (AMA), liver kidney microsomal antibody (anti-
LKM), liver-cytosol spesific antibody (LC-1), anti-soluble
liver antigene/liver pancreas (SLA/LP)), transferrine
saturation, ferritine and urine copper tests were also in
normal ranges. An x-ray of the chest was reported to
show dextrocardia. On radiographic image of esophagus
and gastric passage, gastric corpus was at the right side of
abdominal midline and pylorus and bulbus were located
at the left side. In thoracic computed tomography (CT),
dextrocardia and scars of previous pulmonary infections
were observed (Figure 1). A paranasal sinus CT showed
the findings of chronic sinusitis (Figure 2). In transab-
dominal ultrasonography (US), situs inversus totalis, mild
heterogeneous liver parenchyma with grade I hepatostea-
tosis, choledoc dilatation (11 mm) and mild splenome-
galy were determined. Doppler ultrasonography of portal
vein revealed a mild splenomegaly and dilated portal vein
(14 mm). In endoscopic US, it was noted a choledochal
dilatation without stone or sludge and with a diameter of
11.9 mm. In endoscopic retrograde colangiopancreato-
graphy (ERCP), performed after pharyngeal local
anesthesia and sedation induced with pethidin (50 mg)
and i.v. midazolam (5 mg), a dilatation in extrahepatic
biliary tracts was observed (Figure 3). Following endo-
scopic sphincterotomy, extrahepatic biliary tracts were
swept by using basket and balloon catheter, but any
stone or sludge was not extracted. Since an adequate
decrease in cholestasis parameters was not detected
after sphincterotomy, a liver biopsy was decided to be
performed. In the biopsy material, biliary stasis, rosette
formation, feathery degeneration, giant cell formation
in lobules, diffuse fibrosis, ductal and ductular prolif-
eration and lymphoplasmocytic infiltration in portal
areas were observed (Figures 4, 5 and 6). SBC was
diagnosed with patient’s history, imaging techniques,
clinical and laboratory findings besides histological
f i n d i n g s .T h e r e u p o n ,a1 5m g / k g / d a yd o s eo ft a u r o u r -
sodeoxycholic acid (TUDCA) was administrated to the
patient. During a follow-up period of 9 months, she
has been doing well. The laboratory parameters turn
to normal ranges in two months and in follow-up per-
iod, there was not any abnormal rising in laboratory
parameters.
Figure 1 Thoracic computed tomography scan.I ts h o w s
dextrocardia and scars of previous pulmonary infections.
Figure 2 Paranasal sinus computed tomography scan. It shows
clear chronic sinusitis.
Figure 3 Endoscopic retrograde colangiopancreatography
images. The choledoc duct is dilated moderately and located on
the midline on vertebral axis.
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SI is associated with various gastrointestinal abnormal-
ities such as absence of suprarenal inferior vena cava,
polysplenia syndrome, preduodenal portal vein, duode-
nal atresia or stenosis, tracheoeusophageal fistula (type
C), intestinal malrotation, aberrant hepatic arteria, hypo-
plasia of portal vein, congenital hepatic fibrosis and bili-
ary atresia [5]. In a previous study, it was found that the
gallbladder may lie in the midline or be lateralized with
the bulk of the hepatic mass [6].
Although the etiology is not clear, it has been sug-
gested that SIT and ciliopathy are related to each other.
However, the mechanism has not been explained
entirely. It is suggested that the immobility of nodal cilia
inhibits the flow of extra embryonic fluid during
embryonic period and this leads to SI development [7].
However, primary ciliary dyskinesia (PCD) is observed
only in 25% of SI patients.
Whereas a definition of congenital hepatic fibrosis asso-
ciated with ciliopathy and SIT is reported in the current lit-
erature, there is no data about the concurrence of SIT and
SBC. Our case is possibly the first one in literature in terms
of such SIT and SBC co-existence. Despite there is no clear
evident for the development of SBC in patients with SIT,
considering the cases reported in literature, the following
hypotheses may be proposed. The cilium is a hair like struc-
ture that extends from the cell surface into the extracellular
space and it has an axoneme containing microtubules, and
the microtubules connected with each other with dynein
arms that provide ciliary movement [8]. Electron micro-
scopy of the ciliary microtubules frequently reveals absence
or abnormalities of the outera n d / o ri n n e rd y n e i na r m s .
Especially the mutations of the gene dynein axonemal
heavy chain 11 (DNAH 11) are thought to be associated
with ciliopathy and SI [9]. From various studies, it was
reported that ciliary dyskinesia has a role in the pathogen-
esis of nephronophthisis (NPHP) and polycystic renal dis-
ease (PCD) and the genes that are associated with renal
cystic disease are important for left-right axis determination
of the body plan [10]. NPHP may be associated with liver
fibrosis; patients develop hepatomegaly and moderate portal
fibrosis with mild bile duct proliferation, this pattern differs
from that of classical congenital hepatic fibrosis, whereby
biliary dysgenesis is prominent. Bile duct involvement in
Figure 4 Canalicular cholestasis, with rosette formation.
Hematoxylin and eosin.
Figure 5 Portal fibrosis with ductular proliferation.M a s s o n
trichrome.
Figure 6 Ductal and ductular proliferation.C y t o k e r a t i n7
immunostaining.
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because the epithelial cells lining bile ducts (cholangiocytes)
possess primary cilia. It was suggested that especially the
mutations of the gene NPHP2/inversin is associated with
SI. SI and ciliopathy also cause biliary dysgenenesis, dilata-
tion of biliary tract and portal fibrosis [11,12].
In our case, chronic rhinosinusitis and frequently
recurrent lower respiratory tract infections, abnormal
localization of the main biliary tract (on vertebral axis in
ERCP) and moderate dilated biliary tracts support the
hypothesis of SIT and ciliopathy association.
There is no data about increased incidence of chole-
lithiasis in SIT patients. Furthermore, in several case
reports, it was suggested that pancreatic ductal carcinoma,
autoimmune pancreatitis and sclerosing cholangitis may
develop [13,14]. In our patient, there was not any pancrea-
tic pathology. In magnetic resonance cholangiopancreato-
graphy (MRCP), ERCP and endoscopic US examinations,
there was no finding in favor of cholelithiasis, sclerosing
cholangitis or malignity other than moderate choledochal
dilatation. Hepatic transaminase enzymes and bilirubin
values that were returned to normal ranges with the treat-
ment of a 15 mg/kg/day dose of TUDCA within 2 months
supported our diagnosis.
Due to the following reasons, we consider SBC in this
case and not primary biliary cirrhosis (PBC): 1) first of all,
antimitochondrial antibody was negative in this case; 2)
secondly, there was not any symptomatic presentation that
seen in PBC such as pruritus, hyperpigmentation, xanta-
lesma; 3) thirdly, in ERCP and MRCP images, choledoc
duct was moderately dilated and located on the midline
on vertebral axis; 4) finally, it is impossible to differentiate
PBC or SBC in such a patient with stage 4 liver fibrosis,
but the clinical features and laboratory findings along with
histopathological findings supported the SBC. The major
causes of SBC are gallstones/choledocholityasis, narrowing
of the bile duct following gallbladder surgery, chronic pan-
creatitis, pericholangitis, idiaptahic sclerosing cholangitis,
congenital biliary atresia and cystic fibrosis. In this case, all
causes of SBC mentioned above were excluded.
We concluded that this is the first case in literature
that may indicate the development of SBC in a patient
with SIT.
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